249 related articles for article (PubMed ID: 10470598)
1. Multiple sclerosis and vaccination against hepatitis B: analysis of risk benefit profile.
Tosti ME; Traversa G; Bianco E; Mele A
Ital J Gastroenterol Hepatol; 1999; 31(5):388-91. PubMed ID: 10470598
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccination: risk-benefit profile and the role of systematic reviews in the assessment of causality of adverse events following immunisation.
Jefferson T; Traversa G
J Med Virol; 2002 Jul; 67(3):451-3. PubMed ID: 12116044
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination.
Mikaeloff Y; Caridade G; Assi S; Tardieu M; Suissa S;
Brain; 2007 Apr; 130(Pt 4):1105-10. PubMed ID: 17276994
[TBL] [Abstract][Full Text] [Related]
4. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
[TBL] [Abstract][Full Text] [Related]
5. Vaccinations and risk of central nervous system demyelinating diseases in adults.
DeStefano F; Verstraeten T; Jackson LA; Okoro CA; Benson P; Black SB; Shinefield HR; Mullooly JP; Likosky W; Chen RT;
Arch Neurol; 2003 Apr; 60(4):504-9. PubMed ID: 12707063
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
7. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign.
Mele A; Mariano A; Tosti ME; Stroffolini T; Pizzuti R; Gallo G; Ragni P; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2007 Feb; 44(3):e17-24. PubMed ID: 17205431
[TBL] [Abstract][Full Text] [Related]
8. Development of multiple sclerosis after vaccination against hepatitis B: a study based on human leucocyte antigen haplotypes.
Ozakbas S; Idiman E; Yulug B; Pakoz B; Bahar H; Gulay Z
Tissue Antigens; 2006 Sep; 68(3):235-8. PubMed ID: 16948644
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.
Mele A; Stroffolini T; Zanetti AR
J Med Virol; 2002 Jul; 67(3):440-3. PubMed ID: 12116041
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis B vaccination. Advocating for a protection principle].
Aron E
Bull Acad Natl Med; 2002; 186(2):361-6; discussion 366-8. PubMed ID: 12145843
[TBL] [Abstract][Full Text] [Related]
11. [Long-term efficacy of infant hepatitis B immunization program].
Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
[TBL] [Abstract][Full Text] [Related]
12. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B vaccine and risk of multiple sclerosis.
DeStefano F; Verstraeten T; Chen RT
Expert Rev Vaccines; 2002 Dec; 1(4):461-6. PubMed ID: 12901584
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B vaccination and the risk of multiple sclerosis.
Ascherio A; Zhang SM; Hernán MA; Olek MJ; Coplan PM; Brodovicz K; Walker AM
N Engl J Med; 2001 Feb; 344(5):327-32. PubMed ID: 11172163
[TBL] [Abstract][Full Text] [Related]
15. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.
Ni YH; Huang LM; Chang MH; Yen CJ; Lu CY; You SL; Kao JH; Lin YC; Chen HL; Hsu HY; Chen DS
Gastroenterology; 2007 Apr; 132(4):1287-93. PubMed ID: 17433322
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.
Mikaeloff Y; Caridade G; Suissa S; Tardieu M
Neurology; 2009 Mar; 72(10):873-80. PubMed ID: 18843097
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis.
Mikaeloff Y; Caridade G; Rossier M; Suissa S; Tardieu M
Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1176-82. PubMed ID: 18056563
[TBL] [Abstract][Full Text] [Related]
18. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
19. [Cost-effectiveness analysis of different alternatives of universal vaccination against hepatitis B in the region of Murcia].
Guillén Grima F; Espín Ríos MI
Med Clin (Barc); 1995 Feb; 104(4):130-6. PubMed ID: 7898156
[TBL] [Abstract][Full Text] [Related]
20. Benefits of early hepatitis B immunization programs for newborns and infants.
Van Herck K; Van Damme P
Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]